Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Vs. Other Oral Agents in Type 2 Diabetes: A Real-Life Worldwide Observational Study (Edge)
AuthID
P-006-6VH
P-006-6VH
© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service